Revelation Partners

Revelation Partners is a secondaries investment firm based in Sausalito, California, specializing in providing flexible capital and liquidity solutions across the healthcare ecosystem. The firm focuses on direct investments, fund-of-funds, growth capital, and customized transactions such as fund recapitalizations and continuation funds for healthcare investors, companies, and founders. They target various healthcare subsectors, including telehealth, medtech, diagnostics, therapeutics, and tech-enabled services, offering tailored solutions. Revelation Partners manages over $1.5 billion in total committed capital across 5 closed funds, including a recent $608 million Fund IV and a $350 million third fund. Key personnel include Managing Partners Mike Boggs and Scott Halsted, alongside Partners Andrew Olson, Doug Fisher, and Eric Shiozaki. Revelation Partners was founded in 2015 by Scott Halsted.

High-Level Overview

Revelation Partners is an investment firm specializing in providing flexible capital solutions primarily to rapidly growing, late-stage private healthcare companies. Their mission centers on creating customized liquidity solutions that align shareholders and support long-term business growth. They invest across healthcare sectors including medical devices, biopharmaceuticals, healthcare technology and services, and life science tools and diagnostics. Typically, their investments range from $5 million to $50 million, with participation in deals as large as $1 billion. Revelation Partners actively partners with management teams to help scale businesses, focusing on companies with validated technologies or commercial scale, often with revenues exceeding $20 million[1][2][3].

Origin Story

Founded in 2015 and based in California, Revelation Partners emerged to address the need for liquidity and growth capital in the private healthcare market. The firm was established by experienced partners including Doug Fisher and others who bring deep expertise in healthcare investing. Over time, Revelation Partners has evolved to offer tailored solutions that provide liquidity to shareholders with varying time horizons, including fund managers, corporations, and individual investors. Their approach has expanded to include both direct investments in healthcare companies and fund-of-fund strategies, reflecting a broadening focus within the healthcare private equity ecosystem[1][2][4].

Core Differentiators

• Unique Investment Model: Revelation Partners specializes in customized liquidity solutions that align diverse shareholders’ interests, addressing the challenge of illiquid private holdings.
• Network Strength: The firm leverages strong relationships with healthcare companies, fund managers, and limited partners to facilitate complex transactions.
• Track Record: With over a decade of experience, they have participated in deals ranging from $5 million to $1 billion, demonstrating capability in scaling late-stage healthcare companies.
• Operating Support: They actively partner with management teams, providing strategic support to navigate growth and shareholder alignment.
• Sector Focus: Concentrated expertise in healthcare sectors such as medical devices, biopharmaceuticals, diagnostics, healthcare IT, and consumer health[1][2][3].

Role in the Broader Tech Landscape

Revelation Partners operates at the intersection of healthcare innovation and private capital markets, riding the trend of increasing demand for flexible liquidity solutions in the private healthcare sector. The timing is critical as healthcare companies face longer development cycles and complex shareholder structures. Market forces such as rising healthcare technology adoption, regulatory advancements, and increasing venture/private equity activity favor their model. By providing tailored capital solutions, Revelation Partners helps reduce friction in ownership transitions and accelerates growth, thereby influencing the broader healthcare startup ecosystem and enabling sustained innovation[1][2][3].

Quick Take & Future Outlook

Looking ahead, Revelation Partners is poised to deepen its impact by continuing to tailor liquidity and growth capital solutions that meet the evolving needs of healthcare companies and their investors. Trends such as digital health expansion, personalized medicine, and biopharmaceutical innovation will likely shape their investment focus. Their influence may grow as they help bridge the gap between private healthcare innovation and capital markets, supporting companies through critical scaling phases and shareholder transitions. This positions Revelation Partners as a vital strategic partner in the healthcare investment landscape, reinforcing their mission to build enduring businesses through flexible, customized capital solutions[1][2][4].